Emea Anorexiants Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 124.70 Million |
 Market Size (Forecast Year) |
USD 160.40 Million |
 CAGR |
% |
| Major Markets Players |
欧洲、中东和非洲 (EMEA) 厌食药市场，按药物类别（儿茶酚胺厌食药、血清素厌食药）、药物类型（仿制药、品牌药）、用途（减肥、肥胖症、注意力缺陷多动障碍 (ADHD)、Dravet 综合征）、处方模式（处方、非处方药）、给药途径（口服、肠外）、最终用户（医院、家庭护理、专科中心、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2030 年。
欧洲、中东和非洲地区厌食症市场分析及规模
根据世界卫生组织 (WHO) 的报告，2017 年全球约有 6.5 亿人肥胖，其中 4100 万名 5 岁以下儿童肥胖。厌食药在这方面发挥了重要作用。FDA 已批准了几种治疗肥胖症的药物，预计厌食药市场将在未来几年内增长。主要市场参与者的不断增加以及 EMEA 地区可支配收入庞大的目标人群预计将在 2023-2030 年预测期内推动市场增长。
Data Bridge Market Research 分析了 2023-2030 年预测期内 EMEA 厌食药市场的增长率。在上述预测期内，EMEA 厌食药市场的预期复合年增长率趋于 3.2% 左右。2022 年市场价值为 1.247 亿美元，到 2030 年将增长至 1.604 亿美元。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
欧洲、中东和非洲地区厌食症市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
药物类别（儿茶酚胺类厌食药、血清素类厌食药）、药物类型（仿制药、品牌药）、用途（减肥、肥胖症、注意力缺陷多动障碍 (ADHD)、Dravet 综合征）、处方方式（处方药、非处方药）、给药途径（口服、肠外）、最终用户（医院、家庭护理、专科中心、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
德国、法国、英国、意大利、荷兰、西班牙、俄罗斯、瑞士、沙特阿拉伯、南非、土耳其、奥地利、阿联酋、以色列、挪威、匈牙利、立陶宛、科威特、爱尔兰、埃及、波兰、欧洲其他地区、中东和非洲 |
|
涵盖的市场参与者 |
VIVUS LLC（美国）、F. Hoffmann-La Roche Ltd.（瑞士）、Mylan NV（美国）、赛诺菲（法国）、辉瑞公司（美国）、诺华公司（瑞士）、默克公司（美国）、Lannett（美国）、Bausch Health Companies Inc.（加拿大）、Sun Pharmaceutical Industries Ltd.（印度）、Novo Nordisk A/S（丹麦）、Currax Pharmaceuticals LLC（欧洲、中东和非洲地区）、卫材株式会社（日本）、Recordati Rare Diseases（澳大利亚）、Amphastar Pharmaceuticals, Inc（美国） |
|
市场机会 |
|
市场定义
厌食药，通常称为食欲抑制剂，是一种用于治疗肥胖症的药物。这种药物通过作用于大脑来抑制食欲，从而减少食物消耗。厌食药是中枢神经兴奋剂，有助于减少食欲，有速释片和缓释片两种。这些处方药应与低热量饮食和定期运动结合使用。
欧洲、中东和非洲地区厌食症药物市场动态
驱动程序
- 肥胖率不断上升
全球肥胖发病率的上升将推动该行业的发展。肥胖是一种身体脂肪水平聚集到引起健康问题的程度的疾病。当人们摄入更多的卡路里时，就会出现这种情况。肥胖会增加患上结肠癌、乳腺癌、子宫内膜癌、2 型糖尿病、心血管疾病和肌肉骨骼问题等慢性疾病的风险。根据世界卫生组织的记录，2016 年全球约有 6.5 亿人和 3.4 亿儿童和青少年患有肥胖症。同样，根据经济合作与发展组织 2020 年的报告，预计 2020-2050 年期间，欧洲、中东和非洲地区在肥胖和相关疾病方面的医疗支出将位居全球首位。这将推动市场增长。
- 口服补充剂需求不断增长
医生广泛开口服厌食药来治疗肥胖症。这些药物可以减少大脑的饥饿信号。口服厌食药以处方药和非处方药 (OTC) 形式广泛供应。市场上有多种口服厌食药，例如二乙丙酮、苯甲曲秦、芬特明、氯卡色林、安非他酮/纳曲酮和托吡酯/芬特明，这些药物有助于促进市场增长。
机会
- 口服给药需求不断增长
口服厌食药在过去几年占据了市场主导地位，预计在预测期内仍将如此。这些产品的需求不断增长可能是因为患者对其非侵入性治疗的倾向性增加。同样，它们更容易给药，不需要经过培训的医疗保健专业人员，这增加了患者和医生的采用率。此外，片剂和胶囊产品供应量的增加，以及主要市场参与者的认知度提高，预计将导致该细分市场的增长。
- Rise in Strategic Developments
Some of the major market players are employing numerous strategies such as increased investments in R&D and mergers and acquisitions. For instance, Currax Pharmaceuticals LLC, acquired Nalpropion Pharmaceuticals in September 2019 to focus on the treatment of weight loss. With the acquisition deal, Currax has owned the world-wide rights to Contrave, the number one prescription weight-loss brand medication in the EMEA and Europe. This increases the market growth
Restraints/Challenges
- Lack of Skilled Professionals
Dearth of skilled healthcare professionals unaware of the appropriate use of anorexiants could reduce the growth of the EMEA anorexiants market during the forecast period 2023-2030. Otherwise use of these stimulants could affect the patient badly and lead to the hindrance of the market.
- Side Effects Associated with Anorexiants
There are various side effects that are linked with the anorexiants such as tachycardia, headache, diarrhea, myalgia, insomnia, vomiting, nausea and others will act as a limit and further hinder the growth rate of market
This EMEA anorexiants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the EMEA anorexiants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, VIVUS Inc. launched Qsymia in South Korea for weight loss management. This product launch aided the company in enlarging its foot print in emerging markets that helped it to overcome the losses arising from the established market.
- In 2019, Pfizer Inc. collaborated with Mylan N.V that primarily focused on manufacturing of large number of generic drugs which involves anorexiants drugs. This collaboration assisted the company in enhancing its market of generic anorexiants, which allowed it to earn more revenue growth.
EMEA Anorexiants Market Scope
The EMEA anorexiants market is segmented on the basis of drug class, drug type, applications, prescription mode, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
- Catecholamines Anorexiants
- Serotonin Anorexiants
Indication
- ADHD
- Dravet Syndrome
- Lennox-Gastaut Syndrome
- Obesity
- Weight Loss
- Others
Route of Administration
- Oral
- Subcutaneous
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Anorexiants Market Regional Analysis/Insights
The diabetic assays market is analyzed and market size insights and trends are provided by type, disease type, deployment, end-users and distribution channel as referenced above.
The major countries covered in the diabetic assays market report are Germany, France, U.K., Italy, Netherlands, Spain, Russia, Switzerland, Saudi Arabia, South Africa, Turkey, Austria, UAE, Israel, Norway, Hungary, Lithuania, Kuwait, Ireland, Egypt, Poland, Rest of Europe & Middle East and Africa.
Germany is dominating the market because of the availability of a wide variety of drugs, the increasing geriatric population, and the increasing demand for effective treatment. It is also because of wide presence of number of major market players dealing with the eating disorders and rising children and adult population.
France is the fastest-growing region because of the emerging economical condition and increasing investment of vendors to widely develop the drugs and also increasing prevalence of obesity and eating disorders.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and EMEA Anorexiants Market Share Analysis
The EMEA anorexiants market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, EMEA presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to EMEA anorexiants market.
Key players operating in the EMEA anorexiants market include:
- VIVUS LLC (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)
- Cipla Inc. (EMEA)
- Lannett (U.S.)
- Bausch Health Companies Inc. (Canada)
- Sun Pharmaceutical Industries Ltd. (India)
- Novo Nordisk A/S (Denmark)
- Currax Pharmaceuticals LLC (U.S.)
- Eisai Co., Ltd. (Japan)
- Recordati Rare Diseases (Australia)
- Amphastar Pharmaceuticals, Inc (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
